Search Results

5-fluorouracil in lethal mutagenesis of foot-and-mouth disease virus

Authors: Agudo, Rubén; Arias, Armando; Domingo, Esteban

Source: Future Medicinal Chemistry, Volume 1, Number 3, June 2009 , pp. 529-539(11)

Publisher: Future Science

Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers

Authors: Babalola, C. P.; Kolade, Y. T.; Olaniyi, A. A.; Adedapo, A.; Scriba, G. K. E.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 6, December 2009 , pp. 677-682(6)

Publisher: Blackwell Publishing

Comparison of genetic polymorphisms of the NAT2 gene between Korean and four other ethnic groups

Authors: Kang, T. S.; Jin, S. K.; Lee, J. E.; Woo, S. W.; Roh, J.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 6, December 2009 , pp. 709-718(10)

Publisher: Blackwell Publishing

¹³C breath tests in personalized medicine: fiction or reality?

Author: Modak, Anil S

Source: Expert Review of Molecular Diagnostics, Volume 9, Number 8, November 2009 , pp. 805-815(11)

Publisher: Expert Reviews

A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans

Authors: Mukonzo, Jackson K.; Röshammar, Daniel; Waako, Paul; Andersson, Maria; Fukasawa, Takashi; Milani, Lili; Svensson, Jan Olof; Ogwal-Okeng, Jasper; Gustafsson, Lars L.; Aklillu, Eleni

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 690-699(10)

Publisher: Blackwell Publishing

Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole

Authors: Grün, Barbara; Krautter, Stefanie; Riedel, Klaus-Dieter; Mikus, Gerd

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 712-720(9)

Publisher: Blackwell Publishing

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 12, 1 December 2009 , pp. 761-804(44)

Publisher: Adis International

Oxidation of Endobiotics Mediated by Xenobiotic-Metabolizing Forms of Human Cytochrome P450

Authors: Niwa, Toshiro; Murayama, Norie; Yamazaki, Hiroshi

Source: Current Drug Metabolism, Volume 10, Number 7, September 2009 , pp. 700-712(13)

Publisher: Bentham Science Publishers

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects

Authors: Nassr, Nassr; Huennemeyer, Andreas; Herzog, Rolf; von Richter, Oliver; Hermann, Robert; Koch, Manuela; Duffy, Kevin; Zech, Karl; Lahu, Gezim

Source: British Journal of Clinical Pharmacology, Volume 68, Number 4, October 2009 , pp. 580-587(8)

Publisher: Blackwell Publishing

Genetic factors influencing cytarabine therapy

Author: Lamba, Jatinder K

Source: Pharmacogenomics, Volume 10, Number 10, October 2009 , pp. 1657-1674(18)

Publisher: Future Medicine

Oral bioavailability and brain penetration of (−)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D₁ and antagonist at D₂ receptors, in rats

Authors: Sun, Yan; Dai, Jieyu; Hu, Zheyi; Du, Feifei; Niu, Wei; Wang, Fengqing; Liu, Fei; Jin, Guozhang; Li, Chuan

Source: British Journal of Pharmacology, Volume 158, Number 5, November 2009 , pp. 1302-1312(11)

Publisher: Blackwell Publishing

Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development

Authors: Wang, B.; Zhou, S.-F.

Source: Current Medicinal Chemistry, Volume 16, Number 31, November 2009 , pp. 4066-4218(153)

Publisher: Bentham Science Publishers

Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment

Authors: Malmström, R. E.; Östergren, J.; Jørgensen, L.; Hjemdahl, P.

Source: Journal of Internal Medicine, Volume 266, Number 5, November 2009 , pp. 457-466(10)

Publisher: Blackwell Publishing

Psychotropic drugs and renal failure: Translating the evidence for clinical practice

Authors: Baghdady, Nour; Banik, Suman; Swartz, Shari; McIntyre, Roger

Source: Advances in Therapy, Volume 26, Number 4, April 2009 , pp. 404-424(21)

Publisher: Springer

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine

Authors: Schöller-Gyüre, Monika; Kakuda, Thomas N.; Raoof, Araz; >Goedele De Smedt,; Hoetelmans, Richard M.W.

Source: Clinical Pharmacokinetics, Volume 48, Number 9, 1 September 2009 , pp. 561-574(14)

Publisher: Adis International

Immunotherapy in Elderly Transplant Recipients: A Guide to Clinically Significant Drug Interactions

Author: Kuypers, Dirk R.J.

Source: Drugs & Aging, Volume 26, Number 9, 1 September 2009 , pp. 715-737(23)

Publisher: Adis International

Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis

Authors: Ung, D.; Parkman, H. P.; Nagar, S.

Source: Xenobiotica, Volume 39, Number 10, October 2009 , pp. 749-756(8)

Publisher: Informa Healthcare

Pharmacogenomics and therapeutic strategies for dementia

Author: Cacabelos, Ramón

Source: Expert Review of Molecular Diagnostics, Volume 9, Number 6, September 2009 , pp. 567-611(45)

Publisher: Expert Reviews

Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients

Authors: Park, P.-W.; Seo, Y. H.; Ahn, J. Y.; Kim, K.-A.; Park, J.-Y.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 5, October 2009 , pp. 569-574(6)

Publisher: Blackwell Publishing

Targeting Leukotrienes for the Treatment of COPD?

Authors: Drakatos, Panagis; Lykouras, Dimosthenis; Sampsonas, Fotis; Karkoulias, Kiriakos; Spiropoulos, Kostas

Source: Inflammation & Allergy - Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Volume 8, Number 4, September 2009 , pp. 297-306(10)

Publisher: Bentham Science Publishers